DNA framework-engineered chimeras platform enables selectively targeted protein degradationLi Zhou(Regend Therapeutics (China)), Yi Ma(China Pharmaceutical University)Nature CommunicationsJuly 27, 202310.1038/s41467-023-40244-7Cited by 50SaveCiteExport RISWatch citationsRelated PapersNo related papers foundPowered by citation graph analysis